secwatch.observer — SEC 8-K summary
======================================

Issuer:     Journey Medical Corp (DERM)
CIK:        0001867066
Form:       8-K
Filed at:   2023-01-20T23:59:59+00:00
Accession:  0001104659-23-005408
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Journey Medical CFO resigns; Corporate Controller Benesch named interim CFO effective Jan 27.
--------------------------------------------------------------------------------

- Ernest De Paolantonio resigns as CFO effective Jan 27, 2023; will consult through March 31, 2023.
- Joseph Benesch, Corporate Controller since Nov 2021, appointed interim CFO effective Jan 27, 2023.
- Benesch has over 25 years of finance experience, is a CPA, and previously held senior roles at Teligent and Torrent.
- No immediate change to Benesch's compensation; search for permanent CFO underway internally and externally.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1867066/000110465923005408/0001104659-23-005408-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1867066/000110465923005408/tm234058d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-005408

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer